View allAll Photos Tagged ClinicalTrials
The Moderna mRNA vaccine contains an ingredient known as “SM-102,” which is well documented to be toxic to humans and animals. SM-102 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles. Administration of luciferase mRNA in SM-102-containing lipid nanoparticles induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of lipid nanoparticles for delivery of mRNA-based vaccines.
Check it out for yourself. Go to: www.modernatx.com/patents
Then click on: US 10,703,789
Scroll down the PDF to page 46, Table 4.
Read the list of ingredients in the list, and you will see Luciferase listed three times.
en.wikipedia.org/wiki/Luciferase
Luciferase is a generic term for the class of oxidative enzymes that produce bioluminescence, and is usually distinguished from a photoprotein. The name was first used by Raphaël Dubois who invented the words luciferin and luciferase, for the substrate and enzyme, respectively. Both words are derived from the Latin word lucifer, meaning “lightbearer”, which in turn is derived from the Latin words for “light” (lux) and “to bring or carry” (ferre).
This reminds me of Microsoft patent: WO/2020/060606: patentscope.wipo.int/search/en/detail.jsf?docId=WO2020060606
patents.google.com/patent/WO2020060606A1/en
Human body activity associated with a task provided to a user may be used in a mining process of a cryptocurrency system. A server may provide a task to a device of a user which is communicatively coupled to the server. A sensor communicatively coupled to or comprised in the device of the user may sense body activity of the user. Body activity data may be generated based on the sensed body activity of the user. The cryptocurrency system communicatively coupled to the device of the user may verify if the body activity data satisfies one or more conditions set by the cryptocurrency system, and award cryptocurrency to the user whose body activity data is verified.
Then there is little Elon Musk and his brain computer start-up, which raised $205 million from Google Ventures and others. Neuralink is trying to develop high-bandwidth brain implants that can communicate with phones and computers. And Elon Musk is not the only one developing this antichrist junk. Can you guys and gals see the bigger picture here? Things are setting up to fulfill End Time Bible Prophecy!
www.cnbc.com/2021/07/30/elon-musks-neuralink-backed-by-go...
What happened before the flood? Fallen angelic beings mated with humans, and so mankind had changed from how God had originally created them. This was very wicked in God’s eyes. The fruit of all this was utter wickedness, so God flooded the earth. Now, in our day, they want to merge man and AI. But most people are asleep and clueless. Once people are changed from how God created them, God will once again pour out His wrath upon the earth. This time it will not be a judgment of water—but of fire.
Even if it requires utter destruction of human lives. The British Medical Journal published an investigation report on Clinical Trials of Pfizer Covid-19 vaccine. It is publicly available. Read for yourself.
Depression. I try my best to hide it, but many of ya’ll know about my struggle. I’ve had good years and bad years as I’ve gone through doctors, countless medications, prayer counselors, psychologists, psychiatrists, small groups, friends… There are definitely lots of days when I can’t function and don’t want to live anymore. After 8 years of riding the depression roller coaster, I’m just so tired.
I do have hope in God's bigger plan. I do have a joy that my life does have meaning and purpose. But moving forward everyday is still hard. If ya’ll would please keep me in your prayers this week as I am trying yet another treatment to help me be able to function every day. I’ll be admitted to Emory Hospital next week for a clinical trial involving deep brain stimulation. Thanks.
On a lighter note, I’ve run some 5k’s recently! I traveled with Lou Anne & John to the mountains of Maggie Valley North Carolina to run a “moonlight 5k” and the next weekend ran with my fellow Fit Wit boot campers in the Grant Park 5k. Running is getting slightly easier, but I am still having a hard time running more than 2-3 miles for everyday training. Here are my newbie running times thus far:
Race :: Distance :: Time :: Pace
Fit Wit Mile :: 1mile :: 7:09 :: 7:09
Peachtree Road Race:: 10k :: 60:00 :: 9:40
Maggie Valley :: 5k :: 26:26 :: 8:31
Grant Park :: 5k :: 25:23 :: 8:11
excellent Research - federführende Forschung - Tübingen auf dem Berg - Nordstadt
°
- Max Planck Institute
- TTR Technologiezentrum Tübingen Reutlingen
- Sternwarte
- CureVac AG
Biotechnologieunternehmen
CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA).
The main research primarily focuses on cancer immunotherapies and prophylactic vaccines against infectious diseases
In September 2015, CureVac entered into a collaboration with the International AIDS Vaccine Initiative (IAVI) to accelerate the development of AIDS vaccines, utilizing immunogens developed by IAVI and partners, delivered via CureVac’s mRNA technology.
In November 2015, CureVac raised about $110 million (€100 million) in a private placement to enable expansion of its mRNA development platform and clinical-stage pipeline. CureVac also announced the change of its corporate legal form to a joint stock company, Aktiengesellschaft (AG). This new financing round was led by Baillie Gifford, adding to the approximately $220 million CureVac has raised since its founding in 2000. The new investors, Baillie Gifford, Chartwave Limited, Coppel Family, Northview and Sigma Group, join existing investors dievini Hopp BioTech holding GmbH & Co. KG of Dietmar Hopp and the Bill & Melinda Gates Foundation.
nur englisches wiki ist up to date
Bill & Melinda Gates-Stiftung: „Es geht uns nicht ums Geldverdienen“
Krebsimmuntherapie, et cetera, et cetera, et cetera.
et cetera - &c
(in English; /ɛtˈsɛtərə/; Latin pronunciation: [ɛt ˈkeːtɛra]) (rare: etceteros) (abbreviation: etc. or &c.)
etc.
Since inception, CureVac had received approximately $330 million (€300 million) in equity investments.
From Science to Patients – Ideas Become Treatments at CureVac
-
left to right
just watching, and waiting,
outside my sequestered door. As the oldest in the house... for whom the bell tolls... I prefer the plaintive coos of the nesting owls in the neighboring tree.
Once I accepted the inevitability of exposure, I focused on resistance: boosting my immune system and antivirals. I’ll share what I take daily, and if anyone is aware of any reason to *not* take these in the context of coronavirus, please let me know and I’ll update. I have not had a sick day for decades, and perhaps this helped, but remember that my personal journey is not prescriptive and that none of these have been properly studied to reach any conclusions on efficacy, yet:
1) Vitamin D (+ K2 for better absorption): “Studies have indicated that there is a high prevalence of vitamin D deficiency worldwide. Vitamin D deficiency may affect the immune system as vitamin D plays an immunomodulation role, enhancing innate immunity by up-regulating the expression and secretion of antimicrobial peptides, which boosts mucosal defenses. Furthermore, recent meta-analyses have reported a protective effect of vitamin D supplementation on respiratory tract infections” — WHO and an apparently biased site, but some links: Vitamin D Wiki
2) Magical mushroom powder of Shitake + Maitake: “We found significant stimulation of defense reaction. In all cases, the most active was the Maitake-Shiitake combination” — NIH
3) Coconut oil: “Several in vitro, animal, and human studies support the potential of coconut oil, lauric acid and its derivatives as effective and safe agents against a virus like nCoV-2019. Mechanistic studies on other viruses show that at least three mechanisms may be operating. Given the safety and broad availability of virgin coconut oil (VCO), we recommend that VCO be considered as a general prophylactic against viral and microbial infection.” — Ateneo University
4) Zinc, short term use: “In this study we demonstrate that the combination of Zn(2+) and PT at low concentrations (2 µM Zn(2+) and 2 µM PT) inhibits the replication of SARS-coronavirus (SARS-CoV)” — Researchgate And some warnings about prolonged use: Oregon State
5) Oregano oil capsules: “Mexican oregano oil and its main component, carvacrol, are able to inhibit different human and animal viruses in vitro.” — NIH
And then found to be helpful with other viruses, like norovirus and herpes: “This study provides novel findings on the antiviral properties of oregano oil” — sfamjournals
6) Vitamin C: “2019-nCoV infected pneumonia, namely severe acute respiratory infection (SARI) has caused global concern and emergency. We hypothesize that Vitamin C infusion can help improve the prognosis of patients with SARI. Therefore, it is necessary to study the clinical efficacy” — Clinicaltrials
These are all inexpensive on Amazon, but if you want an even stronger placebo effect, find the most expensive version, as that is proven to work better :) ScienceDaily
7) Update: I have added Quercetin. Its impact on Covid-19 has not yet been properly researched, but the basic mechanism could be similar to Chloroquine, and is an over-the-counter supplement even if you don’t have symptoms. Best with Zinc. From molecular simulation studies: "Liu et al. (2020) successfully crystallised the COVID-19 main protease (Mpro), which is a potential drug target. Quercetin... and curcumin [among others] appeared to have the best potential to act as COVID-19 Mpro inhibitors."
8) I also take NMN + TMG and have been discussing possible downstream NAD+ / sirtuin effects on COVID-19 with David Sinclair of Harvard Medical School. As with all of these, nothing is proven; it's just a fascinating hypothesis. The observed age effect on mortality is stark — the younger a person is, across the spectrum, the lower the death rate and hospitalization rate. Looking to NAD+ depletion as we age, and exacerbated by inflammation, perhaps it's ultimately an energy crisis and a loss of NAD + ATP that does us in.
Snips from his recent book Lifespan:
“NAD boosts the activity of all seven sirtuins. And because NAD is used by over 500 different enzymes, without any NAD, we’d be dead in 30 seconds. NAD acts as a fuel for sirtuins. NAD levels decrease with age throughout the body. Human studies with NAD boosters (NMN and NR) are ongoing. So far, there has been no toxicity, not even a hint of it.” (p.134)
Also: "Most antiviral drugs target specific viral proteins. Consequently, they often work for only one virus, and their efficacy can be compromised by the rapid evolution of resistant variants. There is a need for the identification of host proteins with broad-spectrum antiviral functions, which provide effective targets for therapeutic treatments that limit the evolution of viral resistance. Here, we report that sirtuins present such an opportunity for the development of broad-spectrum antiviral treatments, since our findings highlight these enzymes as ancient defense factors that protect against a variety of viral pathogens." — Researchgate
Sinclair added trimethylglycine (TMG) in a recent podcast. He also mentions not to take NMN or NR at night as they interfere with sleep.
H/T Nova Spivack for the corona-relevant links. He is maintaining a more complete list here.
“Ah, distinctly I remember
it was in the bleak December
And each separate dying ember
wrought its ghost upon the floor.
Much I marvelled this ungainly fowl
to hear discourse so plainly,
Though its answer little meaning—
little relevancy bore
For we cannot help agreeing
that no living human being
Ever yet was blessed with seeing
bird above his chamber door
What this grim, ungainly, ghastly, gaunt,
and ominous bird of yore
Meant in croaking ‘Nevermore.’”
— Edgar Allan Poe
" It's the Catch-22 of clinical trials:
to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them.
In the last few decades, we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. "
Continue reading on Statistically funny,
commenting on the science of unbiased health research with cartoons, by Hilda Bastian
All our posts about the #AllTrials campaign
More on Big Pharma - Clinical Trials - Prescriptions Drugs - the FDA - Pharmaceutical Industry
C1
AV
excellent Research - federführende Forschung - Tübingen auf dem Berg - Nordstadt
°
- Max Planck Institute
- TTR Technologiezentrum Tübingen Reutlingen
- Sternwarte
- CureVac AG
Biotechnologieunternehmen
CureVac is a biopharmaceutical company headquartered in Tübingen, Germany, that develops therapies based on messenger RNA (mRNA).
The main research primarily focuses on cancer immunotherapies and prophylactic vaccines against infectious diseases
In September 2015, CureVac entered into a collaboration with the International AIDS Vaccine Initiative (IAVI) to accelerate the development of AIDS vaccines, utilizing immunogens developed by IAVI and partners, delivered via CureVac’s mRNA technology.
In November 2015, CureVac raised about $110 million (€100 million) in a private placement to enable expansion of its mRNA development platform and clinical-stage pipeline. CureVac also announced the change of its corporate legal form to a joint stock company, Aktiengesellschaft (AG). This new financing round was led by Baillie Gifford, adding to the approximately $220 million CureVac has raised since its founding in 2000. The new investors, Baillie Gifford, Chartwave Limited, Coppel Family, Northview and Sigma Group, join existing investors dievini Hopp BioTech holding GmbH & Co. KG of Dietmar Hopp and the Bill & Melinda Gates Foundation.
nur englisches wiki ist up to date
Bill & Melinda Gates-Stiftung: „Es geht uns nicht ums Geldverdienen“
Krebsimmuntherapie, et cetera, et cetera, et cetera.
et cetera - &c
(in English; /ɛtˈsɛtərə/; Latin pronunciation: [ɛt ˈkeːtɛra]) (rare: etceteros) (abbreviation: etc. or &c.)
etc.
Since inception, CureVac had received approximately $330 million (€300 million) in equity investments.
From Science to Patients – Ideas Become Treatments at CureVac
-
left to right
Most medical research aims to discover more about health and to find new ways to treat or prevent diseases.
Within this, the science of how to make drugs safer has received relatively little research funding and attention.
This is despite the fact that side effects (known as adverse drug reactions) are both a big public health concern and a major barrier to the development of new medicines. Experiencing side effects is unpleasant, and not understanding them is frustrating.
While it's impossible to have a drug with no side effects, this guide explains why they happen and what can be done about them.
The Making Sense of Drug Safety Science new guide form was developed in collaboration with the MRC Centre for Drug Safety Science at the University of Liverpool, 13 Nov 2013.
Sources:
* Making Sense of Drug Safety Science guide
* Sense about Science website, on Facebook and on Twitter
* All our posts about clinical trials and the pharmaceutical industry
Cancer continues to be a dangerous disease that takes the lives of people across the world. Cancer cells need some nutrients to grow and sugar is one of the main compounds, but it is not limited only to it. The recent research shows that cancer cell depends on the amino acid glutamine and researchers and doctors use this discovery for treating cancer disease. In 1955, Doctor Harry Eagle introduced a surprising discovery by pointing out the dependency of cancer cells on glutamine.
For the “Year of Clinical Trial Diversity”, FDA is launching a series of educational videos and materials to raise awareness about the importance of minorities participating in clinical trials. These videos stress the importance of why diversity is needed to help ensure medical products are safe and effective for everyone. Ms. Miller, who is living with sickle cell disease explains why clinical trials need diverse people to discover health disparities—conditions that appear differently in minorities, or affect minorities more frequently.
For more information visit www.fda.gov/ForConsumers/ByAudience/MinorityHealth/ucm472...
The 6 videos in this album (www.flickr.com/photos/fdaphotos/albums/72157669875514195) are downloadable from Flickr and free of all copyright restrictions. Redistribution of these videos via non-internet platforms is allowed. Credit to the U.S. Food and Drug Administration is appreciated but not required.
Conclusion: Fasting and chemotherapy can work miracles. If you are on chemotherapy, fast three days before chemotherapy and one day after. I am not a doctor.
I recently wrote about one possible reason for the evolution of cancer, as a way to euthanase old-age palaeolithic persons who do not undergo periods of starvation, and are likely therefore to have been free-loading on the charity of their peers. In short I hypothesised that cancer may be a natural granny dumping mechanism.
But that got me to thinking about an even more puzzling evolutionary phenomena: why are there old people at all?
The average lifespan of palaeolithic peoples was about 33 years, which is just as it should be from a straightforward evolutionary perspective. If they started breeding at puberty then your average palaeolith would have had time to raise a few children and then die.
The strange thing is however that then, as till quite modern times, it was the high childhood death rate that suppressed average longevity. If a palaeolithic person reached puberty they lived on average into their mid fifties, way past the menopause and optimal male breeding potential. Further, with the agricultural revolution only a few thousand years ago, biblical and modern humans have palaeolithic bodies -- we have had time to evolve lactose tolerance and little else -- with the potential to live at least three score years and ten and four score if strong (Psalm 90).
Even if older palaeolithic persons were undergoing periods of near starvation and were not free-loading, they would have been consuming food which otherwise may have been gathered by their reproducing peers. So, why did evolution allow such grannies and grandfathers to exist at all? We could easily have evolved to self-destruct at 40. To a palaeolithic society living at the calorific brink of annihilation, the existence of post-breeding-age individuals would seem to be a tremendous calorific waste.
One can think of various 'nice' evolutionary-favoured tasks that post-reproduction-aged palaeolithic people could have performed, such as child minding or as a source of wisdom. I propose a task more tragic: older persons evolved as to function as in vivo experiments, commonly called 'guinea pigs'.
In any hunter gather society -- go out into the woods and try it today -- there would have been a lot of lean times. There would be very few apples, but a vast number of species of berries, bark, and beetles (and that is just the b's) with varying degrees of food value, nutrients, calories and toxicity. When (hunter) gatherers were lucky they found known fruits and roots to fulfil their dietary needs, but they were continually on the brink, regularly going without food, and faced with risky choices of culinary behaviour. "I have not eaten in a week. Do I try these berries or not? Do I give them to my children?"
Herein lies the great evolutionary value of the existence or granny and grandfather aged people like me. "Wait a minute son. Don't eat that. Don't give it to the little one. Let me try it. I will tell you in a day!" (When I think of all my ancestors that surely must have done this it makes me cry.) Societies which contained such individuals would continually increase the variety of gathered food sources and only lose the occasional non-breeding human guinea pig.
I reach this conclusion bearing in mind the miraculous research being carried out NOW on the synergy between chemotherapy and short term starvation in the treatment of cancer. The graph above left (Shi et al., 2012) shows tumour size in mice xenografted with human skin cancer. Cisplatin (CDDP), the most common chemotherapeutic drug, shows negligible effect in reducing tumour size. Short Term Starvation (STS) has a significant but small effect. Short term starvation combined with Cisplatin chemotherapy creates a synergy which seems nothing short of miraculous. 60% percent of the cancerous mice went into remission whereas no or negligible mice went into remission in the other two conditions. The same paper (ibid) also shows similar results, in vitro, with lung cancers.
Dr Valter Longo, the pioneer whose research on fasting lead to the discovery of this chemo-fasting synergy (e.g. Raffaghello, Safdie, Bianchi, Dorff, Fontana, & Longo 2010; Lee, & Longo, 2011), argues that fasting causes ordinary cells to go into hibernation mode, whereas cancer cells keep demanding more food. If in that period of starvation one consumes, or is injected with a toxin, then it is only cancerous cells that are killed. If one keeps fasting for about a day after the consumption or injection of the toxin, until the toxin has left ones system, then the toxin hardly effects normal cells at all.
This synergy between chemotherapy and no-calorie consumption suggests an explanation for both the existence of cancer, and the existence of old people. Old people get cancer. But many of them may be able to cure their own cancer if they undergo regular periods of fasting combined with the consumption of toxins. In modern society this experience is one that perhaps only cancer patients will undergo in the form of chemotherapy but in a (hunter) gathering palaeolithic society it would have experience that would regularly and necessarily have been faced. Going through that starvation plus toxin experience and coming out the other side, or not ("no, don't eat that...urk"), would have been evolutionarily favoured. So evolution worked out a way to create such individuals with that propensity: it created individuals that have a self destruct mechanism that is cured by starvation and toxin consumption. Palaeolithic societies that evolved to have older non-breeding individuals
-- Guinea Pig People (GPPs) -- to do the toxin tasting would have been able to gather and consume more food, breed more and continue the species. And here we are, thanks to all our GPPs.
In conclusion, it seems to me, a non-doctor, from limited research, fasting and chemotherapy can work miracles. If you are on chemotherapy, consult with your oncologist and consider fasting three days before chemotherapy and one day after, because it may cure your cancer, and makes perfect evolutionary sense.
Graph above: Figure 3A and 3B from Shi et al., 2012
Bibliography
Shi, Y., Felley-Bosco, E., Marti, T. M., Orlowski, K., Pruschy, M., & Stahel, R. A. (2012). Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin. BMC cancer, 12(1), 1.
bmccancer.biomedcentral.com/articles/10.1186/1471-2407-12...
Lee, C., & Longo, V. D. (2011). Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene, 30(30), 3305-3316.
Nowell, P. C. (1976). The Clonal Evolution of Tumor Cell Populations. Science, 194(4260), 23-28.
Raffaghello, L., Safdie, F., Bianchi, G., Dorff, T., Fontana, L., & Longo, V. D. (2010). Fasting and differential chemotherapy protection in patients. Cell Cycle, 9(22), 4474-4476.
The theory above - post breeding age persons are guinea pigs - is a little similar to the 'disposable soma' theory of the evolution of ageing at a societal rather than cellular level.
rspb.royalsocietypublishing.org/content/205/1161/531.short
"Organisms that do not age are essentially in a steady state in which chronologically young and old individuals are physiologically the same. In this situation the synthesis of macromolecules must be sufficiently accurate to prevent error feedback and the development of lethal 'error catastrophes'. This involves the expenditure of energy, which is required for both kinetic proof-reading and other accuracy promoting devices. It may be selectively advantageous for higher organisms to adopt an energy saving strategy of reduced accuracy in somatic cells." (Kirkwood, Holliday, 1979)
Somatic cells are non-reproductive cells.
These non reproducing cells are argued to be disposable to facilitate greater "proof reading" and prevent "error catastrophes" in the reproducing cells. I am suggesting above that somatic people (non reproducing people) are there, and yet disposable, there to be disposed of, to facilitate "proof reading" (toxin tasting - "reduced accuracy" in diet) and prevent error catastrophes in the non-somatic, reproductive population.
Relatedly
Peto's paradox (there is no correlation between animal size and cancer rate)
www.ncbi.nlm.nih.gov/pmc/articles/PMC3060950/
The assumption that there should be a correlation seems to be based on the assumption that cancer is a random occurrence in cells, so the more of them the greater the chance of cancer, as opposed to a more deliberate, non-random self destruct mechanism proposed here. Cancer is not random. It is a deliberate way of killing old people who do not fast be guinea pigs.
A healthy volunteer receives an experimental universal influenza vaccine known as H1ssF_3928 as part of a Phase 1 clinical trial at the NIH Clinical Center in Bethesda, Maryland. Scientists at NIAID’s Vaccine Research Center (VRC) developed the vaccine.
Read more: www.nih.gov/news-events/news-releases/nih-begins-first-hu...
Credit: National Institute of Allergy and Infectious Diseases/NIH
Volunteer in trial of candidate universal flu vaccine BPL-1357 receives an intramuscular injection. Credit: NIAID
To learn more, see June 28, 2022 press release, "Trial of Potential Universal Flu Vaccine Opens at NIH Clinical Center" at www.niaid.nih.gov/news-events/trial-potential-universal-f....
Nourishing on spiritual levels, particularly for those feeling restless and dissatisfied, or those with addictive tendencies. Helps in finding positive outlets, including artistic for energy and expression. Brings balance for meditation.
Bach believed that illness was the result of a conflict between the purposes of the soul and the personality's actions and outlook. This internal war, according to Bach, leads to negative moods and to "energy blocking", thought to cause a lack of "harmony", thus leading to physical diseases. Bach derived his solutions intuitively[ and based on his perceived psychic connections to the plants, rather than using research based on scientific methods. If Bach felt a negative emotion, he would hold his hand over different plants, and if one alleviated the emotion, he would ascribe the power to heal that emotional problem to that plant. He imagined that early-morning sunlight passing through dew-drops on flower petals transferred the healing power of the flower onto the water,[15] so he would collect the dew drops from the plants and preserve the dew with an equal amount of brandy to produce a mother tincture which would be further diluted before use.[16] Later, he found that the amount of dew he could collect was not sufficient, so he would suspend flowers in spring water and allow the sun's rays to pass through them.[15] If this was impractical because of lack of sunlight or other reasons, he wrote that the flowers may be boiled. The result of this process Bach termed the "mother tincture", which is then further diluted before sale or use. Bach was satisfied with the method, because of its simplicity, and because it involved a process of combination of the four elements: The earth to nurture the plant, the air from which it feeds, the sun or fire to enable it to impart its power, and water to collect and be enriched with its beneficent magnetic healing.
By the time of his death in 1936 at 50 years of age, Bach had created a system of 38 different flower remedies along with their corresponding theories of ailments.
Bach flower remedies (BFRs) are solutions of brandy and water—the water containing extreme dilutions of flower material developed by Edward Bach, an English homeopath, in the 1930s. Bach claimed that the dew found on flower petals retains the supposed healing properties of that plant.[1] Systematic reviews of clinical trials of Bach flower solutions have found no efficacy beyond that of a placebo.
The Bach flower remedy solutions, which contain a 50:50 mix of water and brandy, are called mother tincture.[4] Stock remedies—the solutions sold in shops—are dilutions of mother tincture into other liquid. Most often the liquid used is alcohol, so that the alcohol level by volume in most stock Bach remedies is between 25 and 40%[5][better source needed] (50 to 80 proof). The solutions do not have a characteristic scent or taste of the plant because of dilution. The dilution process results in the statistical likelihood that little more than a single molecule may remain; it is claimed that the remedies contain "energetic" or "vibrational" nature of the flower and that this can be transmitted to the user.[2] The solutions are described by some as vibrational medicines,[6][better source needed] which implies they rely on the pseudoscientific concept of water memory. They are often labeled as homeopathic because they are extremely diluted in water, but are not homeopathy as they do not follow other homeopathic ideas such as the law of similars.
The hypothesis that flower remedies are associated with effects beyond a placebo response is not supported by data from rigorous clinical trials.
All randomized double-blind studies, whether finding for or against the solutions, have suffered from small cohort sizes but the studies using the best methods found no effect over placebo.[3][2] The most likely means of action for flower remedies is as placebos, enhanced by introspection on the patient's emotional state, or simply being listened to by the practitioner. The act of selecting and taking a remedy may act as a calming ritual.
Most of the available evidence regarding the efficacy and safety of BFRs has a high risk of bias. We conclude that, based on the reported adverse events in these six trials, BFRs are probably safe. Few controlled prospective trials of BFRs for psychological problems and pain exist. Our analysis of the four controlled trials of BFRs for examination anxiety and ADHD indicates that there is no evidence of benefit compared with a placebo intervention.
Bach flower remedies are an alternative or complementary treatment that is used for emotional problems and pain. They're made out of watered-down extracts from the flowers of wild plants. Edward Bach, a medical doctor and homeopath, created these remedies in the early 1900s.
The center of a Tulip bud is known for being almost perfectly symmetrical. It has a geometric pattern of a hexagram. This is the symbol of the human position between the cosmos and the Earth. Tulip brings balance like the inward and outward expressions, like the tides of water being pulled by the Moon. Tulip helps us to see deeper and find balance within the shadow. Ruled by the Moon Tulip empowers us to make our own decisions through self-value and personal knowledge confidently. Planetary characteristics: Venus
Latin Name: Tulipa X gensneriana
Seven of Hearts: The Chariot & Tulip
From The Flower Attunement Guidebook-
The Tulip brings the feeling that spring has arrived in the northern hemisphere. Its assortment of beautiful chalice-like petals reaches high to the heavens but holds various sacred geometric patterns inside. In this flower essence from the Tulip, we look inside to see the patterns of the hexagrams; this is a symbol of the human position between the cosmos and the Earth, the inward and outward expression in nature like the tides of the water being pulled by the cycles of the Moon. This acknowledgment brings us psychic awareness into a fully embodied Venus quality of personal growth and self-value and worth. Tulip brings balance and stability in the search for personal growth and enlightenment. Tulip flower essence helps us to embody wisdom from the stars giving us insight and keeping us connected to Mother Earth.
Flower essence tinctures work by modifying energy flow through the typical acupuncture meridians. Shifts in these energetic patterns influence the consciousness in helpful ways, both emotionally and physically. These homeopathic remedies can be described as “vibrational” or energy medicine. Flowers themselves contain the highest concentration of life force energy of the plant. Through the sun infusion method, we can harness the flower's healing vibrational pattern and energy. This is imprinted in the water and then preserved as medicine. Preserved with brandy but can be replaced with glycerin upon request.
A Tulip's flower essence is only the plant's vibration, and no plant material is used in the harvesting process.
This can be used as a tincture ingested neat or added to water, tea, or whatever you feel. I recommend one drop in water three times a day. All of the essences can also be added to a bath.
1/2oz 15ml
Made intentionally by hand in Portland, OR
***Disclaimer
results vary and are not 100% guaranteed.
The blends are not intended to replace any medical or mental treatments by a qualified health physician. This information is for educational purposes.
primroseapothecary.com/flower-essences/tulipfloweressence
Flower remedies are sometimes promoted as being capable of boosting the immune system, but "there is no scientific evidence to prove that flower remedies can control, cure or prevent any type of disease, including cancer". Each solution is used alone or in conjunction with other solutions, and each flower is said by advocates to impart specific qualities. Remedies are usually taken orally.
The solutions may be recommended by a naturopath or by a trained Bach flower practitioner after an interview.
The best known solution product is the Rescue Remedy combination, which contains an equal amount each of rock rose, impatiens, clematis, star of Bethlehem and cherry plum remedies. Rescue Remedy is a trademark and other companies produce the same formula under other names, such as Five Flower Remedy.[10] Rescue Cream contains the same remedies in a cream form, with the addition of crab apple.
Drug development is a risky business. More than half of candidate drugs that look promising in the research lab will ultimately fail. More than a quarter of drugs that reach the clinical trial stage will be rejected as ineffective. However, the wealth of genomic information now available through public databases - in particular, the rapidly growing number of known associations between diseases and specific genes - may significantly improve the drug-development success rate. At least, success rates will improve if drug developers let genomics guide their choice of molecular targets for research, according to a team of pharmaceutical industry and academic scientists.
Credit: Ernesto del Aguila III, NHGRI.
Life-saving "medical foods" - formulas designed to help manage patients with inborn errors of metabolism (IEMs)- may actually cause harm when used in excess. Such medical foods should be scientifically reformulated and tested in clinical trials.
Credit: Darryl Leja, NHGRI.
" Deciphering trial outcomes can be a tricky business. As if many measures aren't hard enough to make sense of on their own, they are often combined in a complex maneuver called a composite endpoint (CEP) or composite outcome. The composite is treated as a single outcome. And journalists often phrase these outcomes in ways that give the impression that each of the separate components has improved."
Read: Let's Play Outcome Mash-up - A Clinical Trial Shortcut Classic!, Statistically funny, February 8, 2015, by author and cartoonist Hilda Bastian.
For the “Year of Clinical Trial Diversity”, FDA is launching a series of educational videos and materials to raise awareness about the importance of minorities participating in clinical trials. These videos stress the importance of why diversity is needed to help ensure medical products are safe and effective for everyone. Ms. Miller, who is living with sickle cell disease explains why clinical trials need diverse people to discover health disparities—conditions that appear differently in minorities, or affect minorities more frequently.
For more information visit www.fda.gov/ForConsumers/ByAudience/MinorityHealth/ucm472...
This video is downloadable from Flickr and free of all copyright restrictions. Redistribution of this video via non-internet platforms is allowed. Credit to the U.S. Food and Drug Administration is appreciated but not required. To embed this video on your website, please use the YouTube embed code at www.youtube.com/watch?v=kIzOeZedkoA
For the “Year of Clinical Trial Diversity”, FDA is launching a series of educational videos and materials to raise awareness about the importance of minorities participating in clinical trials. These videos stress the importance of why diversity is needed to help ensure medical products are safe and effective for everyone. Ms. Miller, who is living with sickle cell disease explains why clinical trials need diverse people to discover health disparities—conditions that appear differently in minorities, or affect minorities more frequently.
For more information visit www.fda.gov/ForConsumers/ByAudience/MinorityHealth/ucm472...
This video is downloadable from Flickr and free of all copyright restrictions. Redistribution of this video via non-internet platforms is allowed. Credit to the U.S. Food and Drug Administration is appreciated but not required. To embed this video on your website, please use the YouTube embed code at www.youtube.com/watch?v=Q4iPlW0Glz0
For the “Year of Clinical Trial Diversity”, FDA is launching a series of educational videos and materials to raise awareness about the importance of minorities participating in clinical trials. These videos stress the importance of why diversity is needed to help ensure medical products are safe and effective for everyone. In this video, FDA’s Acting Chief Scientist, explains FDA’s role in increasing clinical trial diversity.
For more information visit www.fda.gov/ForConsumers/ByAudience/MinorityHealth/ucm472...
This video is downloadable from Flickr and free of all copyright restrictions. Redistribution of this video via non-internet platforms is allowed. Credit to the U.S. Food and Drug Administration is appreciated but not required. To embed this video on your website, please use the YouTube embed code at www.youtube.com/watch?v=wSjjS7M5jts
For the “Year of Clinical Trial Diversity”, FDA is launching a series of educational videos and materials to raise awareness about the importance of minorities participating in clinical trials. These videos stress the importance of why diversity is needed to help ensure medical products are safe and effective for everyone. Ms. Miller, who is living with sickle cell disease explains why healthy volunteers can participate in clinical trials.
For more information visit www.fda.gov/ForConsumers/ByAudience/MinorityHealth/ucm472...
This video is downloadable from Flickr and free of all copyright restrictions. Redistribution of this video via non-internet platforms is allowed. Credit to the U.S. Food and Drug Administration is appreciated but not required. To embed this video on your website, please use the YouTube embed code at www.youtube.com/watch?v=fkZ_4mwJLPM
For the “Year of Clinical Trial Diversity”, FDA is launching a series of educational videos and materials to raise awareness about the importance of minorities participating in clinical trials. These videos stress the importance of why diversity is needed to help ensure medical products are safe and effective for everyone. Ms. Miller, who is living with sickle cell disease explains the benefits of participating in clinical trials.
For more information visit www.fda.gov/ForConsumers/ByAudience/MinorityHealth/ucm472...
This video is downloadable from Flickr and free of all copyright restrictions. Redistribution of this video via non-internet platforms is allowed. Credit to the U.S. Food and Drug Administration is appreciated but not required. To embed this video on your website, please use the YouTube embed code at www.youtube.com/watch?v=U1-3_5aYaMs
For the “Year of Clinical Trial Diversity”, FDA is launching a series of educational videos and materials to raise awareness about the importance of minorities participating in clinical trials. These videos stress the importance of why diversity is needed to help ensure medical products are safe and effective for everyone. Ms. Miller, who is living with sickle cell disease explains how to find information on clinical trials.
For more information visit www.fda.gov/ForConsumers/ByAudience/MinorityHealth/ucm472...
This video is downloadable from Flickr and free of all copyright restrictions. Redistribution of this video via non-internet platforms is allowed. Credit to the U.S. Food and Drug Administration is appreciated but not required. To embed this video on your website, please use the YouTube embed code at www.youtube.com/watch?v=6FGGquOrVic
Discover the architectural gem that is the San Francisco VA Medical Center, an exemplar of mid-20th-century modernism set against the city’s dynamic backdrop. Designed with precision and functionality in mind, this institution has stood as a beacon of medical excellence. Its minimalist aesthetic, characterized by clean lines and an unadorned facade, reflects the era’s design ethos where form follows function. The architect employed a utilitarian approach while ensuring resilience and timelessness—a true testament to San Francisco’s rich architectural tapestry. With its strategic location offering both accessibility and serenity, this historic structure not only serves veterans but also stands as an enduring piece of San Francisco’s storied past.
NIH researchers found that our brains may store memories in neuronal firing patterns that are replayed fractions of a second before remembering.
Read more: www.nih.gov/news-events/news-releases/scientists-monitore...
Credit: National Institute of Neurological Disorders and Stroke, NIH
Unpublished and misreported studies make it difficult to determine the true value of a treatment. Peter Doshi and colleagues call for sponsors and investigators of abandoned studies to publish (or republish) and propose a system for independent publishing if sponsors fail to respond.
A call to publish—or be published
A call to action, publishing trials, credibly
Call for restorative authors and participating journals
Read Unmasking 'Invisible' Drug Trials
by Jennifer Couzin-Frankel, ScienceInsider, 13 June 2013
Sources: Restoring invisible and abandoned trials: a call for people to publish the findings, by Peter Doshi, 13 June 2013
Brain metastases are the condition when cancer cells spread from its original place to the brain. Any cancer cells can reach your brain, causing complicated and life-threatening situation. Some types of cancers are more likely to travel to your brain, including lung, breast, colon, kidney, melanoma, and more. Brain metastases are also called secondary brain tumors. The data has revealed that nearly 10 to 20 percent of adults develop such brain tumor with cancer. With the growth of these metastatic tumors, they create pressure on the brain and bring changes in the function of surrounding brain tissues. There are many signs and symptoms associated with this.
Pamela E. Scott, Ph.D., is Deputy Director and Director of Research and Development, FDA Office of Women’s Health.
This photo is free of all copyright restrictions and is available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. Privacy and use information: www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
Scientists are in a real bind when it comes to peer review. It’s hard to be objective when we’re all among the peer reviewing and peer-reviewed, or plan to be. Still, we should be able to mobilize science’s repertoire to solve our problems.
Read Weighing Up Anonymity and Openness in Publication Peer Review on PLOS blogs, and Peer Review BC (Before Citations) on PLOS blogs by Hilda Bastian, May 13 and April 20, 2015.
I was delighted to have the chance to envizualize (create large scale visual notes) for the Disruptive Innovations to Advance Clinical Trials Conference in Boston. From the conference website: "This conference is designed for drug development innovative thinkers who are determined to re-invent clinical trials. It is an outcomes-focused program that not only delves deeply into the key strategic factors impeding clinical trial productivity, but also endeavors to connect change makers who can share current solutions, propose new solutions and commit to testing them and share the results."
Lilliam Rosario, Ph.D., is Director, Office of Computational Science, Office of Translational Sciences, at FDA’s Center for Drug Evaluation and Research. She's also a contributor to FDA Voice.
This photo is free of all copyright restrictions and available for use and redistribution without permission. Credit to the U.S. Food and Drug Administration is appreciated but not required. For more privacy and use information visit: www.flickr.com/people/fdaphotos/
FDA photo by Michael J. Ermarth
Research Nurse Jennifer Cunningham, B.S.N., looks on as a healthy volunteer receives an infusion of CIS43LS, an experimental monoclonal antibody against malaria, as part of a Phase 1 clinical trial.
Read more about the study: www.nih.gov/news-events/news-releases/first-human-trial-m...
Credit: National Institute of Allergy and Infectious Diseases, NIH
A drug approved to treat a severe form of asthma dramatically improved the health of people with rare chronic immune disorders called hypereosinophilic syndromes (HES) in whom other treatments were ineffective or intolerable. This finding comes from a small clinical trial led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and conducted through a partnership with the global biopharmaceutical company AstraZeneca. The results were published online on April 3, 2019 in the New England Journal of Medicine.
In this image: Activated eosinophils in the peripheral blood of a patient with idiopathic hypereosinophilic syndrome.
Read more: www.nih.gov/news-events/news-releases/fda-approved-drug-e...
Credit: National Institute of Allergy and Infectious Diseases/NIH
Dr. Marta Čeko of the NCCIH Division of Intramural Research prepares a participant for a CAT scan in an NCCIH study on pain.
NCCIH’s Portal on Pain Information: nccih.nih.gov/health/pain
Credit: National Center for Complementary and Integrative Health, National Institutes of Health
Many hands make tight work
"Crowdsourcing research can balance discussions, validate findings and better inform policy" say Raphael Silberzahn and Eric L. Uhlmann.
Health cartoons
* Image sources: nature, 07 October 2015.
* Enjoy our health cartoons album on Flickr.
Related posts
* Our posts tagged research and medical research video playlist.